James E Dentzer
First SEC filing: Oct. 3, 2022 · Latest: Oct. 3, 2022
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| July 31, 2026 | IMNN | A | 6,934 | $1.59 | $11,025 | 21,897 Direct | +46.34% | Acquired | -19.5% (price as of 2026-10-02) |
| July 7, 2026 | CRIS | A | 110,090 | $5.29 | $582,376 | 110,090 Direct | · | Acquired | -84.8% (price as of 2026-10-02) |
| May 22, 2026 | IMNN | A | 11,148 | $2.20 | $24,526 | 14,963 Direct | +292.21% | Acquired | -41.8% (price as of 2026-10-02) |
| March 20, 2026 | CRIS | C | 100 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| March 20, 2026 | CRIS | C | 133,333 | · | · | 148,730 Direct | +865.97% | Acquired | (price as of 2026-10-02) |
| March 17, 2026 | CRIS | A | 133,333 | · | · | 133,333 Direct | · | Acquired | (price as of 2026-10-02) |
| March 17, 2026 | CRIS | A | 133,333 | · | · | 133,333 Direct | · | Acquired | (price as of 2026-10-02) |
| March 17, 2026 | CRIS | A | 133,333 | · | · | 133,333 Direct | · | Acquired | (price as of 2026-10-02) |
| March 17, 2026 | CRIS | A | 100 | · | · | 100 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 2, 2026 | IMNN | A | 4,405 | · | · | 4,405 Direct | · | Acquired | (price as of 2026-10-02) |
| Aug. 4, 2025 | IMNN | A | 3,318 | $9.20 | $30,526 | 3,318 Direct | · | Acquired | -84.0% (price as of 2026-10-02) |
| Aug. 4, 2025 | IMNN | A | 250 | · | · | 250 Direct | · | Acquired | (price as of 2026-10-02) |
| May 20, 2025 | CRIS | A | 360,000 | $3.13 | $1,126,800 | 360,000 Direct | · | Acquired | -98.7% (price as of 2026-10-02) |
| March 14, 2025 | IMNN | A | 3,750 | · | · | 3,750 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 28, 2025 | CRIS | A | 40,000 | $3.13 | $125,200 | 40,000 Direct | · | Acquired | -98.7% (price as of 2026-10-02) |
| Sept. 6, 2024 | IMNN | A | 3,634 | · | · | 17,301 Direct | +26.59% | Acquired | (price as of 2026-10-02) |
| June 12, 2024 | IMNN | A | 4,500 | · | · | 13,667 Direct | +49.09% | Acquired | (price as of 2026-10-02) |
| May 21, 2024 | CRIS | A | 100,000 | $11.62 | $1,162,000 | 100,000 Direct | · | Acquired | -99.7% (price as of 2026-10-02) |
| March 15, 2024 | IMNN | A | 4,500 | · | · | 9,167 Direct | +96.42% | Acquired | (price as of 2026-10-02) |
| March 17, 2023 | IMNN | A | 2,000 | · | · | 4,667 Direct | +74.99% | Acquired | (price as of 2026-10-02) |
| Jan. 20, 2023 | CRIS | A | 1,000,000 | · | · | 1,000,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Sept. 30, 2022 | IMNN | A | 2,667 | · | · | 2,667 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 31, 2022 | CRIS | S 10b5-1 | 3,094 | $3.07 | $9,499 | 64,877 Direct | -4.55% | Disposed | -99.9% (price as of 2026-10-02) |
| Jan. 29, 2022 | CRIS | A | 825,000 | · | · | 825,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 27, 2022 | CRIS | S | 2,406 | $3.18 | $7,651 | 67,971 Direct | -3.42% | Disposed | -99.9% (price as of 2026-10-02) |
| Jan. 28, 2021 | CRIS | A | 330,000 | · | · | 330,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 26, 2021 | CRIS | S 10b5-1 | 3,094 | $10.59 | $32,765 | 67,268 Direct | -4.40% | Disposed | -100.0% (price as of 2026-10-02) |
| Jan. 25, 2021 | CRIS | S | 2,283 | $10.96 | $25,022 | 70,362 Direct | -3.14% | Disposed | -100.0% (price as of 2026-10-02) |
| March 2, 2020 | CRIS | A | 750,000 | · | · | 750,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 24, 2020 | CRIS | S 10b5-1 | 3,094 | $1.64 | $5,074 | 42,158 Direct | -6.84% | Disposed | -99.9% (price as of 2026-10-02) |
| Jan. 23, 2020 | CRIS | S 10b5-1 | 3,658 | $1.69 | $6,182 | 45,252 Direct | -7.48% | Disposed | -99.9% (price as of 2026-10-02) |
| May 23, 2019 | CRIS | A | 1,115,871 | · | · | 1,115,871 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 24, 2019 | CRIS | S 10b5-1 | 3,094 | $1.16 | $3,589 | 41,639 Direct | -6.92% | Disposed | -99.8% (price as of 2026-10-02) |
| Jan. 23, 2019 | CRIS | S 10b5-1 | 2,397 | $1.09 | $2,613 | 44,733 Direct | -5.09% | Disposed | -99.8% (price as of 2026-10-02) |
| Sept. 26, 2018 | CRIS | A | 750,000 | · | · | 750,000 Direct | · | Acquired | (price as of 2026-10-02) |
| May 15, 2018 | CRIS | A | 825,000 | · | · | 825,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 22, 2018 | CRIS | A | 206,250 | · | · | 212,011 Direct | +3580.11% | Acquired | (price as of 2026-10-02) |
| March 29, 2016 | CRIS | A | 1,700,000 | · | · | 1,700,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 14, 2014 | CRIS | A | 650,000 | · | · | 650,000 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| July 7, 2026 | CRIS | Employee stock option (right to buy) | Common Stock | $5.29 | July 6, 2036 | 110,090 | Acquired |
| March 20, 2026 | CRIS | Series B Convertible Preferred Stock | Common Stock | · | · | 100 | Disposed |
| March 17, 2026 | CRIS | Series C Warrant (right to buy) | Common Stock | $0.75 | July 8, 2027 | 133,333 | Acquired |
| March 17, 2026 | CRIS | Series B Warrant (right to buy) | Common Stock | · | · | 133,333 | Acquired |
| March 17, 2026 | CRIS | Series A Warrant (right to buy) | Common Stock | $0.75 | Jan. 8, 2031 | 133,333 | Acquired |
| March 17, 2026 | CRIS | Series B Convertible Preferred Stock | Common Stock | · | · | 100 | Acquired |
| Jan. 2, 2026 | IMNN | Stock Option (Right to Buy) | Common Stock | · | Jan. 2, 2036 | 4,405 | Acquired |
| Aug. 4, 2025 | IMNN | Stock Option (Right to Buy) | Common Stock | · | Aug. 4, 2035 | 250 | Acquired |
| May 20, 2025 | CRIS | Employee stock option (right to buy) | Common Stock | $3.13 | Jan. 27, 2035 | 360,000 | Acquired |
| March 14, 2025 | IMNN | Stock Option (Right to Buy) | Common Stock | · | March 14, 2035 | 3,750 | Acquired |
| Jan. 28, 2025 | CRIS | Employee stock option (right to buy) | Common Stock | $3.13 | Jan. 27, 2035 | 40,000 | Acquired |
| Sept. 6, 2024 | IMNN | Stock Option (Right to Buy) | Common Stock | · | Sept. 6, 2034 | 3,634 | Acquired |
| June 12, 2024 | IMNN | Stock Option (Right to Buy) | Common Stock | · | June 12, 2034 | 4,500 | Acquired |
| May 21, 2024 | CRIS | Employee stock option (right to buy) | Common Stock | $11.62 | Jan. 18, 2034 | 100,000 | Acquired |
| March 15, 2024 | IMNN | Stock Option (Right to Buy) | Common Stock | · | March 15, 2034 | 4,500 | Acquired |
| March 17, 2023 | IMNN | Stock Option (Right to Buy) | Common Stock | · | March 17, 2033 | 2,000 | Acquired |
| Jan. 20, 2023 | CRIS | Employee stock option (right to buy) | Common Stock | $0.70 | Jan. 19, 2033 | 1,000,000 | Acquired |
| Sept. 30, 2022 | IMNN | Option (right to buy) | Common Stock | $1.68 | Sept. 30, 2032 | 2,667 | Acquired |
| Jan. 29, 2022 | CRIS | Employee stock option (right to buy) | Common stock | $3.09 | Jan. 28, 2032 | 825,000 | Acquired |
| Jan. 28, 2021 | CRIS | Employee stock option (right to buy) | Common stock | $9.14 | Jan. 27, 2031 | 330,000 | Acquired |
| March 2, 2020 | CRIS | Employee stock option (right to buy) | Common stock | $1.26 | March 1, 2030 | 750,000 | Acquired |
| May 23, 2019 | CRIS | Employee stock option (right to buy) | Common Stock | $1.16 | Jan. 20, 2029 | 1,115,871 | Acquired |
| Sept. 26, 2018 | CRIS | Employee stock option (right to buy) | Common stock | $1.62 | Sept. 25, 2028 | 750,000 | Acquired |
| May 15, 2018 | CRIS | Employee stock option (right to buy) | Common stock | $0.69 | Jan. 21, 2028 | 825,000 | Acquired |
| March 29, 2016 | CRIS | Employee stock option (right to buy) | Common stock | $1.51 | March 29, 2026 | 1,700,000 | Acquired |
| Feb. 14, 2014 | CRIS | Employee stock option (right to buy) | Common stock | $2.63 | Feb. 13, 2027 | 650,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Oct. 3, 2022 | IMNN | Common Stock | 0 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2021 | $590,212 | · | · | · | $378,780 | · | $21,039 | $3,390,187 |
| 2020 | $544,900 | · | · | · | $476,685 | · | $14,189 | $1,672,849 |
| 2018 | · | · | · | · | · | · | · | · |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.